abstract
- Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403-16. 33378609.
In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- March 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- COVID-19 (MeSH)
- COVID-19 Vaccines (MeSH)
- Humans (MeSH)
- RNA, Messenger (MeSH)
- SARS-CoV-2 (MeSH)
- Vaccines (MeSH)
published in
- ACP journal club Journal